Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Bilici, Ahmet; Uysal, Mukremin; Menekse, Serkan; Akin, Semih; Yildiz, Fatih; Turan, Merve; Sezgin Goksu, Sema; Beypinar, Ismail; Sakalar, Teoman; Degirmenci, Mustafa; Erdem, Dilek; Basaran, Gul; Olmez, Omer Fatih; Avci, Nilufer; Tural, Deniz; Sakin, Abdullah; Turker, Sema; Demir, Atakan; Temiz, Suleyman; Kaplan, Muhammed Ali; Dogan, Mutlu; Tanriverdi, Ozgur; Bilgetekin, Irem; Cinkir, Havva Yesil; Acikgoz, Ozgur; Paydas, Semra; Uslu, Ruchan; Turhal, Serdar

doi:10.1080/07357907.2021.2017952

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Tarih

2022

Yazarlar

Bilici, Ahmet

Uysal, Mukremin

Menekse, Serkan

Akin, Semih

Yildiz, Fatih

Turan, Merve

Sezgin Goksu, Sema

Beypinar, Ismail

Sakalar, Teoman

Degirmenci, Mustafa

DOI No

10.1080/07357907.2021.2017952

Diğer Tanımlayıcı No

WOS:000734258300001

Yayınevi

TAYLOR \& FRANCIS INC

Anahtar kelimeler

Everolimus, exemestane, metastatic breast cancer, hormone receptor\\-positive, HER \\- negative, efficacy

URI

https://openaccess.acibadem.edu.tr/handle/11443/7100

Koleksiyonlar

WOS

Tam öğe sayfası

Real-Life Analysis of Efficacy and Safety of Everolimus Plus Exemestane in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2-Negative Metastatic Breast Cancer Patients: A Turkish Oncology Group (TOG) Study

Tarih

Yazarlar

Süreli Yayın başlığı

Süreli Yayın ISSN

Cilt Başlığı

ISSN

DOI No

Diğer Tanımlayıcı No

Cilt

Sayı

Yayınevi

Özet

Açıklama

Anahtar kelimeler

Alıntı

URI

Koleksiyonlar

Endorsement

Review

Supplemented By

Referenced By